I have stopped posting very frequently on this board because of much of the nonsense that occurs here...mostly shorts with their own agenda. That being said, I will post my summary of the CC in hopes of getting some constructive input...so here it is.
FINANCIALS
# You can read the fine details in the PR, but what is notable that although the company remains operating at a loss there are 2 notable items --> 1. company has not been borrowing any more money to continue operations 2. the company remains EBID pos of about 2 million dollars.
# Gross margin of 37.4% due to TSA, that being said, they still expect gross margin to be 42-44%
# Company has been working with NOBLE/CHARDAN Financial to explore how to solidify company financials
1. Base case --> continue with the current method of operation (no specific mention of renegotiating with DMRJ per se)
2. Replacement of debt
3. Acelerate growth through aquisition of technology
# Currently there are about 78,860,000 shares; the company has debt of 65,000,000; of that 5.1 million dollars is in 0.08 converts resulting in a possible additional 63,000,000 shares outstanding
PRODUCTION/FUTURE SALES:
# Production is humming along
# CATSA order will be fulfilled this fiscal year; full TSA order will also be fulfilled this year
# Next TSA order not yet known, ECAC is now awarding contracts in the 2nd wave of sales
# New handheld will be done and marketed this fiscal year, primarily to replace the 2000 already existing units; additional sales will come from the drug detection market
# Expect middle east and china sales to increase
# In terms of integration, there is not one company that has been designated to be the integrator. That being said the company did state that its technology is coveted and the company will likely integrate through multiple companies
STOCK PRICE
# Caller mentioned that stock price remains volitale due to retail nature of investors; company states that they have miminal vision of what is going on in regards to who is selling the stock; Company is trying to uplist, but at this time still have requirements to fulfill; Company also trying to increase institutional investors
Once again, there was really no mention of how the debt will be handled, no specific mention of DMRJ. The debt is due soon, so we will see how this one goes.
GLTA.
KB